Hepatitis C Virus Epidemiology in Lithuania: Situation before Introduction of the National Screening Programme

Egle Ciupkeviciene1, Janina Petkeviciene1, Jolanta Sumskiene2

  • 1Health Research Institute, Faculty of Public Health, Lithuanian University of Health Sciences, LT47181 Kaunas, Lithuania.

Viruses
|June 24, 2022
PubMed

Insights

Lithuanian primary care centers screened nearly 5000 individuals for hepatitis C virus (HCV) infection, finding a 1.7% prevalence. This highlights the effectiveness of integrating HCV screening into routine healthcare, especially for at-risk populations.

Area of Science:

  • Hepatology
  • Public Health
  • Infectious Diseases

Background:

  • Lithuania implemented a national strategy in 2022 for hepatitis C virus (HCV) screening, including general practitioners and at-risk groups.
  • HCV infection remains a significant global health concern, necessitating effective screening and management strategies.

Purpose of the Study:

  • To evaluate HCV-related mortality trends in Lithuania from 2010-2020.
  • To determine the prevalence of HCV infection among patients with liver diseases.
  • To assess the feasibility and yield of HCV screening in a primary healthcare setting.

Main Methods:

  • Age-standardized mortality rates for chronic hepatitis C and liver diseases were calculated.
  • HCV infection data were collected from patients with liver cirrhosis, cancer, and transplant recipients at Kauno Klinikos.
  • A pilot HCV screening program was conducted at a primary healthcare center in Klaipeda, assessing anti-HCV prevalence and risk factors.

Main Results:

  • No consistent trend in HCV-related mortality was observed between 2010 and 2020.
  • High HCV prevalence was found in patients with liver diseases: 40.5% with cirrhosis, 49.7% with cancer, and 36.9% post-transplant.
  • The pilot screening identified a 1.7% anti-HCV prevalence (2.1% in men, 1.3% in women) among 4867 participants.
  • Risk factors for HCV infection included blood transfusions, prior blood donation (pre-1993), and tattoos.

Conclusions:

  • HCV screening in primary care settings is effective, demonstrating active patient participation.
  • Integrating HCV screening into primary care is crucial for identifying infections, particularly among individuals with liver diseases and those with specific risk factors.
  • The study underscores the importance of continued efforts in HCV detection and management within the Lithuanian healthcare system.

Related Concept Videos